Baillie Gifford

Baillie Gifford International Concentrated Growth

International Mega-cap Growth

Jun 2026 → Jun 2026

Our archive holds 1 letter from this strategy, behind 5 investment theses and positions in 10 companies. Every quote below is copied verbatim from the letter it came from.

1 letter in a year — follow all of Baillie Gifford for every strategy.

What it bought and sold

  • TrimmedDelivery HeroJun 2026
    These new additions were funded by the reduction of holdings that have continued to perform strongly, TSMC and ASML in particular, as well as Delivery Hero and French luxury business Kering, which has been improving following some difficult years.
  • ExitedBioNTechJun 2026
    We also sold our holding in the German biotechnology company BioNTech, where the abrupt announcement of the founders' departure, including the CEO, raised governance concerns we were unable to resolve.
  • TrimmedKeringJun 2026
    These new additions were funded by the reduction of holdings that have continued to perform strongly, TSMC and ASML in particular, as well as Delivery Hero and French luxury business Kering, which has been improving following some difficult years.
  • TrimmedTSMCJun 2026
    These new additions were funded by the reduction of holdings that have continued to perform strongly, TSMC and ASML in particular, as well as Delivery Hero and French luxury business Kering, which has been improving following some difficult years.
  • New positionSK HynixJun 2026
    We added three new holdings to the portfolio during the quarter: SK Hynix, Lonza and CATL.
  • New positionCATLJun 2026
    We added three new holdings to the portfolio during the quarter: SK Hynix, Lonza and CATL.
  • New positionLonzaJun 2026
    We added three new holdings to the portfolio during the quarter: SK Hynix, Lonza and CATL.
  • TrimmedASMLJun 2026
    These new additions were funded by the reduction of holdings that have continued to perform strongly, TSMC and ASML in particular, as well as Delivery Hero and French luxury business Kering, which has been improving following some difficult years.

Its investment theses

Every letter